On October 23, 2014, U.S. Congressman Goodlatte (R-VA) introduced the “Innovation Act,” which is intended “to make improvements and technical corrections” to the Leahy-Smith America Invents Act (AIA…
The first set of "technical corrections" to the Leahy-Smith America Invents Act (AIA) was enacted on January 14, 2013. While this legislation did make "technical" corrections to some of the new AIA…
Recent U.S. Court of Appeals for the Federal Circuit and USPTO decisions underscore the potential value of challenging a granted U.S. patent in a USPTO proceeding, even if the patent already has…
On June 13, 2013, the U.S. Supreme Court issued its long-awaited decision in the “ACLU/Myriad” gene patents case (Association For Molecular Pathology v. Myriad Genetics, Inc.). In a unanimous opinion…
Patent trolls, also called "non-practicing entities" ("NPE"), a rather more elegant name, have become a serious threat to the patent system, particularly in the IT arena in the United States ("U.S…
On June 4, 2013, the U.S. White House issued a press release announcing its “Task Force on High-Tech Patent Issues.” The press release outlined five executive actions and seven legislative…
In a divided en banc decision, the U.S. Court of Appeals for the Federal Circuit affirmed the district court's holding that the claims at issue in CLS Bank v. Alice Corporation are invalid under the…
On April 15, 2013, the U.S. Supreme Court will hear oral arguments in one of the most controversial and publicized biotech patent cases, the “ACLU/Myriad” gene patenting case (formally, The…
The first-inventor-to-file provisions of the America Invents Act (AIA) took effect on March 16, 2013. While the effective date provisions for the first-inventor-to-file provisions are complicated,…
Now that we are less than one month away from implementation of the First-Inventor-To-File provisions of the America Invents Act (AIA), stakeholders are considering whether to file new patent…
